SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-23-000007
Filing Date
2023-02-14
Accepted
2023-02-14 06:46:13
Documents
42
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q siox-20221231.htm   iXBRL 10-Q 809330
2 EX-31.1 a12312210qsioxexhibit311.htm EX-31.1 11009
3 EX-32.1 a12312210qsioxexhibit321.htm EX-32.1 7144
  Complete submission text file 0001636050-23-000007.txt   3293458

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20221231.xsd EX-101.SCH 21238
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20221231_cal.xml EX-101.CAL 33622
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20221231_def.xml EX-101.DEF 90998
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20221231_lab.xml EX-101.LAB 313528
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20221231_pre.xml EX-101.PRE 184217
36 EXTRACTED XBRL INSTANCE DOCUMENT siox-20221231_htm.xml XML 411849
Mailing Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036
Business Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 23622144
SIC: 2834 Pharmaceutical Preparations